NYSE Post
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Technology
  • Research
  • Sport
  • World Media
  • Health
  • USA
No Result
View All Result
NYSE Post
No Result
View All Result
Home Health

Inovio Pharmaceuticals Incorporation (NYSEMKT:INO) has been basking with the glow of positive results

Kevin Goodings by Kevin Goodings
11/29/2022
in Health
Reading Time: 2 mins read
0
0
SHARES
83
VIEWS
Share on FacebookShare on Twitter

Boston, MA, 08/01/2013 (nysepost) – Recently, the stock of Inovio Pharmaceuticals Inc (NYSEMKT:INO) has found to shot up a larger 28.97% with the total number of 15.1 million shares being traded. On a technical view, the stock of Inovio Pharmaceuticals Inc has shot past the price of $ 1.50 stubborn level prior to 11.00 a.m. trading. However, the stock was found to take off during post 12.00 p.m. trading. Therefore, the stock has broken out of the increasing trend in triangle pattern. This led to the measuring implication which is the projected price of approximately $ 2.37. In this week’s trading, the shares of Inovio Pharmaceuticals Inc have also hit a new 12-month high. During the previous trading session, the stock of Inovio Pharmaceuticals Inc has earned a profit 0.69% at the price of $ 1.45 with the total numbers of 4.1 million shares being traded.

The stock of Inovio Pharmaceuticals Inc has been basking with the glow of positive results with regards to the human telomerase reverse transcriptase DNA vaccine for cancer which were administered into two of the animal models by making use of the CELLECTRA. The CELLECTRA is the adaptive technology of electroporation delivery of the vaccines.  It has been announced by Inovio Pharmaceuticals Inc that the company’s hTERT DNA cancer vaccine has shown the potential for reducing the tumors and also for preventing the recurrence of tumors.

Per the reports by media, the focus of Inovio Pharmaceuticals Inc on oncology is holding the chances for making it an appropriate candidate for getting acquired by Merck. This is because Merck is suffering decline in the revenue from its oncology businesses. This has possibly helped the launch of of Inovio Pharmaceuticals Inc into one of the bullish trajectories. Inovio Pharmaceuticals Inc is a company that is re-owned for revolutionizing the vaccines that are intended for the prevention and treatment of cancers and some of the infectious diseases.

Previous Post

Scope Of Facebook Inc (NASDAQ:FB) In Mobile Ad Space

Next Post

MannKind Corporation (NASDAQ:MNKD) shares decline by 4.10%

Next Post

MannKind Corporation (NASDAQ:MNKD) shares decline by 4.10%

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Saudi Arabia says will diversify oil economy to slow climate change

11/27/2022

Rogers Committing to More 4k TV For 2016

11/29/2022

Pentagon: Russian Federation, USA agree to minimize risks in Syrian skies

11/29/2022

Donald Trump Opens Commanding Lead in New CNN Poll

11/29/2022

Peyton Manning Suffers Setback in Fridays Practice

11/29/2022

White House hails ‘momentum’ in Senate’s Supreme Court pick

11/28/2022

Hack the Pentagon: US military invites hackers to test security

11/29/2022

US Cuba Continue To Have Deep Differences on Human Rights

11/27/2022

Facebook makes change to Messenger system

11/28/2022

Sept 10 Apple Inc. (NASDAQ:AAPL) episode fuels talk of innovative iPhone introduction

11/28/2022

NLRB hearing on union at Tenn. Volkswagen plant concludes

11/29/2022

Pathologist is 1st defense witness in Gray trial

11/29/2022

Analysts expect US Fed to raise rates this week

11/29/2022

EU leaders set June 30 deadline for new border force

11/29/2022

Democrats, unions celebrate victories in Illinois primaries

11/29/2022

Teva To Buy Rrimsa for About 2.3 Billion

11/28/2022
logo

Our next winner could be in your inbox tomorrow!

  • About us
  • Disclaimer
  • Contact Us

Categories

  • Business
  • Entertainment
  • Health
  • Markets
  • Politics
  • Research
  • Sport
  • Technology
  • USA
  • World Media

Recent News

Chuck Hagel gets grilled by Republicans in Senate hearing

11/28/2022

Trump, still not conceding defeat, hails vaccine progress

11/28/2022

© 2007-2025 All rights reserved - NysePost.com

No Result
View All Result
  • Home

© 2007-2025 All rights reserved - NysePost.com

Go to mobile version